Johnson & Johnson vaccine paused over rare blood clots
By Rachel Schraer
Johnson & Johnson Shots to Stay Scarce in U.S. Until Plant Is Approved, White House Official Says (Published 2021)
By Julie Bosman, Mitch Smith & Heather Murphy
U.S. states face steep decline in J&J Covid vaccine amid production problems at Baltimore plant
By Emma Newburger
Johnson & Johnson Vaccinations Paused After Rare Clotting Cases Emerge (Published 2021)
By Carl Zimmer, NOAH WEILAND & Sharon LaFraniere